Immunocore Holdings (IMCR) Gross Margin (2021 - 2026)
Immunocore Holdings' Gross Margin came in at 99.06% for Q2 2026, up 0.12 percentage points from 98.94% a year earlier but down 0.53 percentage points from the prior quarter.
Immunocore Holdings (IMCR) Gross Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immunocore Holdings reported Gross Margin of 98.90%, down 0.36 percentage points year-over-year; for FY2025, it came in at 98.73%, down 0.39 percentage points from FY2024.
- Gross Margin carries a five-year change of -1.27 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 99.12% in FY2024 (-0.46 pp), 99.58% in FY2023 (+3.20 pp), 96.39% in FY2022 (-3.63 pp) and 100.01% in FY2021 (+0.01 pp).
- The five-year range for quarterly Gross Margin is 97.41% (Q4 2025) to 100.00% (Q4 2021).
- Year-over-year, Gross Margin increased in four of the last eight quarters, with an average year-over-year change of -0.14 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2025 (a gain of 1.20 percentage points), and the weakest in Q4 2025 (a drop of 2.19 percentage points).
- Business Quant data shows IMCR's Gross Margin at 99.59% (Q1 2026), 97.41% (Q4 2025) and 99.51% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Immunocore Holdings | 1.58 Bn | -1.90 Bn | 114.84 Mn | 99.06% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.06% |
| Mar 31, 2026 | 99.59% |
| Dec 31, 2025 | 97.41% |
| Sep 30, 2025 | 99.51% |
| Jun 30, 2025 | 98.94% |
| Mar 31, 2025 | 99.11% |
| Dec 31, 2024 | 99.61% |
| Sep 30, 2024 | 99.44% |
| Jun 30, 2024 | 97.74% |
| Mar 31, 2024 | 99.65% |
| Dec 31, 2023 | 99.71% |
| Sep 30, 2023 | 99.57% |
| Jun 30, 2023 | 98.17% |
| Mar 31, 2023 | 99.60% |
| Dec 31, 2022 | 99.77% |
| Sep 30, 2022 | 99.85% |
| Jun 30, 2022 | 99.23% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 100.00% |
Immunocore Holdings Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=IMCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();